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Abstract	
Objectives:	we	aimed	to	investigate	if	different	protocols	of	electrical	stimulation	following	
nerve	 injury	 might	 improve	 neuropathic	 pain	 outcomes	 and	 modify	 associated	 plastic	
changes	at	the	spinal	cord	level.	
Materials	 and	Methods:	Adult	 rats	were	 subjected	 to	 sciatic	 nerve	 transection	 and	 repair,	
and	distributed	 in	 4	 groups:	 untreated	 (SNTR,	 n=12),	 repeated	 acute	 electrical	 stimulation	
(rAES,	50	Hz,	1	h,	n=12),	chronic	electrical	stimulation	(CES,	50	Hz,	1	h,	n=12),	and	increasing-
frequency	chronic	electrical	stimulation	(iCES,	1	h,	n=12)	delivered	during	2	weeks	following	
the	lesion.	The	threshold	of	nociceptive	withdrawal	to	mechanical	stimuli	was	evaluated	by	
means	 of	 a	 Von	 Frey	 algesimeter	 during	 3	 weeks	 postlesion.	 Spinal	 cord	 samples	 were	
processed	 by	 immunohistochemistry	 for	 labeling	 glial	 cells,	 adrenergic	 receptors,	 K+-Cl-	
cotransporter	2	(KCC2)	and	GABA.	
Results:	acute	electrical	stimulation	(rAES,	50	Hz,	1	h)	delivered	at	3,	7	and	14	days	induced	
an	 immediate	 increase	 of	 mechanical	 pain	 threshold	 that	 disappeared	 after	 a	 few	 days.	
Chronic	electrical	 stimulation	given	daily	 reduced	mechanical	hyperalgesia	until	 the	end	of	
follow-up,	 being	more	 sustained	with	 the	 iCES	 than	with	 constant	 50Hz	 stimulation	 (CES).	
Chronic	 stimulation	 protocols	 restored	 the	 expression	 of	 	 β2	 adrenergic	 receptor	 and	 of	
KCC2	in	the	dorsal	horn,	which	were	significantly	reduced	by	nerve	injury.	These	treatments	
decreased	also	the	activation	of	microglia	and	astrocytes	in	the	dorsal	horn.	
Conclusion:	 daily	 electrical	 stimulation,	 especially	 if	 frequency-patterned,	 was	 effective	 in	
ameliorating	hyperalgesia	 after	nerve	 injury,	 and	partially	 preventing	 the	proinflammatory	
and	hyperalgesic	changes	in	the	dorsal	horn	associated	to	neuropathic	pain.	
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1.	Introduction	
Neuropathic	 pain	 is	 often	 resistant	 to	 conventional	 pharmacological	 therapeutical	
interventions.	 Non-pharmacological	 approaches	 have	 been	 also	 investigated	 for	 their	
potential	 in	 attenuating	 neuropathic	 pain.	 Electrical	 nerve	 stimulation,	 through	 either	
percutaneous	 leads	 or	 implantable	 stimulation	 devices,	 has	 been	 used	 as	 an	 alternative	
treatment	 for	 a	 variety	 of	 chronic	 pain	 conditions.	 Experimental	 and	 clinical	 studies	 have	
provided	 evidence	 that	 electrical	 stimulation	 of	 injured	 peripheral	 nerves	may	 be	 a	 good	
option	 for	 the	 control	 of	 neuropathic	 pain,	 including	 cases	 of	 traumatic	 nerve	 damage,	
neuroma,	postherpetic	neuralgia	and	diabetic	neuropathy	(1-3).		
However,	 the	 optimal	 characteristics	 of	 electrical	 stimulation	 for	 providing	 effective	
analgesia	 have	not	 been	 fully	 defined	 yet.	 Peripheral	 neurostimulation	 techniques	 applied	
differ	on	the	type	and	location	of	electrodes	and	the	intensity	and	frequency	of	stimulation.	
These	 factors,	 together	with	 the	pattern	of	peripheral	nerve	activation,	may	be	 related	 to	
the	differences	in	the	therapeutic	outcomes	reported.	The	majority	of	previous	studies	used	
low	 intensity	 currents	 to	 treat	 neuropathic	 pain,	 adjusted	 to	 evoke	 mild	 non-painful	
sensations,	varying	the	frequency	in	a	wide	range	(i.e.	2-100	Hz)	(4-7).	A	constant	frequency	
of	 50	 Hz	 is	 the	 most	 commonly	 used	 for	 pain	 therapy	 in	 clinical	 protocols.	 However,	 an	
increasing-frequency	 pattern	 of	 sensory	 inputs	 induced	 by	 physical	 exercise	 has	 been	
demonstrated	to	be	more	effective	than	a	constant	rhythm	in	the	reduction	of	neuropathic	
pain	in	animal	models	(8-9).		
The	 mechanisms	 of	 action	 of	 neurostimulation	 remain	 partially	 unknown.	 The	 original	
explanation	postulated	that	orthodromic	stimulation	of	large	sensory	nerve	fibers	activates	
interneurons	 in	 the	 dorsal	 horn	 of	 the	 spinal	 cord	 which	 modulate	 the	 processing	 of	
nociceptive	 information,	 following	 the	 gate	 control	 theory.	 Another	 explanation	 is	 that	
electrical	 stimulation	 directly	 alters	 the	 excitability	 of	 peripheral	 nerve	 fibers,	 reducing	
activation	of	primary	nociceptive	afferents.	It	has	been	also	suggested	that	nerve	stimulation	
modulates	neurotransmission	at	the	spinal	cord,	involving	changes	in	opioid	and	glutamate	
receptors	 (10).	 In	 addition,	 it	 may	 influence	 the	 activity	 of	 descending	 pain	 suppressing	
pathways,	acting	by	releasing	catecholamines	at	 the	dorsal	horn.	 Indeed,	 	pharmacological	
stimulation	of	adrenoceptors	(11-12)	reduced	neuropathic	pain	after	nerve	 injuries,	and	β2	
receptors	also	participate	in	the	reduction	of	hyperalgesia	induced	by	treadmill	running	after	
nerve	injury	(13).	The	activation	of	β2	receptors	may	contribute	to	regulate	the	activation	of	
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microglia	 in	 the	 spinal	 cord	 induced	 by	 nerve	 injury	 (14-15),	 which	 on	 turn	 leads	 to	
generation	 of	 neuropathic	 pain.	 Reactive	 microglia	 increase	 the	 production	 of	 some	
neurotrophic	factors,	such	as	BDNF.	BDNF	is	able	to	downregulate	the	K+-Cl-	cotransporter	2	
(KCC2)	 in	 the	dorsal	horn	neurons,	 resulting	 in	 increased	excitability	and	hyperalgesia	 (16-
19).	Another	mechanism	that	can	be	modified	by	peripheral	nerve	stimulation	is	the	release	
of	GABA	by	inhibitory	interneurons	in	the	dorsal	horn	(20).	All	these	possible	changes	at	the	
dorsal	horn	network	after	a	nerve	injury	contribute	to	the	development	of	neuropathic	pain.		
In	 this	 study,	we	 investigated	 if	 repeated	 single	 sessions	 or	 daily	 and	 patterned	 electrical	
stimulation	following	nerve	injury	improve	neuropathic	pain	outcomes	and	modify	some	of	
the	potentially	involved	mechanisms,	such	as	glial	reactivity,	expression	of	KCC2	and	GABA	in	
the	spinal	cord.		
	
2.	Materials	and	methods		
2.1.	Animals	and	surgery		
Adult	 female	Sprague–Dawley	rats	 (240±30	g)	were	housed	 in	standard	cages	and	kept	on	
standard	 laboratory	 food	 and	 water	 ad	 libitum	 with	 a	 light–dark	 cycle	 of	 12	 h.	 All	
experimental	 procedures	 were	 approved	 by	 the	 Ethics	 Committee	 of	 the	 Universitat	
Autònoma	de	Barcelona	and	followed	the	guidelines	of	the	European	Commission	on	Animal	
Care	(EU	Directive	2010/63/EU).	Rats	were	anesthetized	by	intraperitoneal	(i.p.)	injection	of	
ketamine	 (10	 mg/kg,	 Imalgene	 500)	 and	 xylazine	 (1	 mg/kg,	 Rompun),	 and	 lidocaine	 was	
applied	 at	 the	 skin	 prior	 to	 incision	 to	 minimize	 surgical	 pain.	 Rats	 were	 submitted	 to	 a	
sciatic	 nerve	 transection	 and	 repair	 (SNTR),	 a	 well-characterized	 model	 that	 allows	 the	
evaluation	of	neuropathic	pain	and	nerve	regeneration	(21-22).	The	right	sciatic	nerve	was	
exposed	at	mid-thigh,	 transected	at	92	mm	 from	 the	 tip	of	 the	 third	 toe,	and	 repaired	by	
epineural	sutures	(10-0	Ethilon),	maintaining	the	fascicular	alignment	of	tibial,	peroneal	and	
sural	branches.		
For	delivering	electrical	stimulation,	rats	were	implanted	with	a	wire	system,	so	they	could	
be	stimulated	daily	without	the	need	of	anesthesia.	A	unipolar	system	electrode	of	1	channel	
made	 of	 stainless	 steel	 with	 ground	 (MS303/3-AIU/SPC,	 5	 cm	 long,	 PlasticsOne	 Inc.,	
Roanoke,	 VA,	 USA)	 was	 attached	 to	 a	 3D	 plastic	 pedestal.	 The	 pedestal	 was	 fixed	 with	
sutures	 to	 the	muscle	 fascia	and	 the	 skin	on	 the	back	of	 the	 rat	 (23).	 The	electrode	wires	
were	placed	in	a	stress-release	loop	to	allow	for	leg	movements	without	pulling,	and	the	tips	
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were	passed	under	 the	gluteus	maximus	muscle	 to	 the	sciatic	nerve.	The	ground	 lead	was	
trimmed	 to	 a	 shorter	 length	 and	 the	 cathode	 lead	 was	 twisted	 around	 the	 sciatic	 nerve	
proximal	to	the	lesion.	Finally,	the	wound	was	closed	in	layers	and	disinfected	with	povidone	
iodine.	Rats	were	kept	in	a	warm	environment	until	complete	recovery	from	anesthesia.	
	
2.2.	Experimental	design		
Animals	 were	 randomly	 divided	 in	 4	 groups	 following	 SNTR:	 untreated	 rats	 (group	 SNTR,	
n=12),	 repeated	 acute	 electrical	 stimulation	 (group	 rAES,	 n=12),	 chronic	 electrical	
stimulation	(group	CES,	n=12),	and	increasing-frequency	chronic	electrical	stimulation	(group	
iCES,	n=12).	A	group	of	naïve	rats	(n=6)	was	added	for	comparison	with	injured	rats.		
Electrical	stimulation	was	performed	while	the	rats	were	free	to	move	in	individual	standard	
cages.	In	the	rAES	group,	stimulation	sessions	of	one	hour	duration	were	performed	at	3,	7	
and	 14	 days	 post	 injury	 (dpi),	 delivering	 pulses	 of	 0.1	 ms	 duration	 and	 suprathreshold	
intensity	 (~3	 V)	 at	 50	 Hz	 (Grass	 S44,	 Quincy	MA).	 A	 stimulation	 frequency	 of	 50	 Hz	 was	
chosen	based	on	preliminary	studies	in	which	we	compared	acute	stimulation	delivered	at	2,	
20,	50	and	100	Hz,	and	found	that	the	50	Hz	frequency	was	the	most	efficient	producing	an	
hypoalgesic	 effect	 (data	 not	 shown).	 Chronic	 stimulation	 treatments	 (CES	 and	 iCES)	 were	
delivered	one	hour	daily	from	3	until	14	dpi.	CES	was	applied	following	the	same	pattern	of	
stimulation	than	rAES.	The	iCES	group	had	the	same	timing	and	duration	of	stimulation	than	
the	CES	group,	but	with	a	pattern	mimicking	the	locomotion	steps	performed	by	rats	 in	an	
increasing	 treadmill	 training	 protocol	 previously	 described	 (9,	 24).	 The	 frequency	 of	 steps	
was	 extrapolated	 and	 transformed	 into	 trains	 of	 pulses.	 Each	 train	 was	 composed	 of	 20	
pulses	of	0.1	ms	duration	and	 suprathreshold	 intensity,	 given	at	50	Hz.	The	 train	duration	
was	400	ms	and	the	train	rate	was	 increasing	0.13	trains	per	second	(tps)	every	5	minutes	
from	0.67	tps	until	2.1	tps	at	the	end	of	one	hour.	The	total	number	of	pulses	in	1	hour	was	
99720,	and	for	the	full	duration	of	the	treatment	1196640.	We	observed	the	slight	twitches	
induced	 by	 stimulation	 on	 gluteus	 and	 biceps	 femoris	 muscles,	 that	 are	 close	 to	 the	
stimulation	 leads,	 to	 ensure	 that	 stimulation	 was	 effectively	 delivered	 suprathreshold	 for	
Aαβ	fibers.	
	
2.3.	Assessment	of	sensory	function		
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Three	 days	 before	 surgery,	 all	 the	 injured	 animals	 were	 habituated	 to	 the	 experimental	
devices,	 and	 then	 tested	 for	 baseline	 values.	 The	 threshold	 of	 nociceptive	 responses	 to	
mechanical	stimuli	was	evaluated	on	both	hindpaws	by	means	of	algesimetry	tests	at	0,	3,	7,	
14	and	21	dpi.	Algesimetry	tests	were	performed	before,	immediately	after	(-post),	one	hour	
(-post+1h)	 and	 five	 hours	 (-post+5h)	 after	 treatment	 sessions	 (rAES,	 CES	 and	 iCES)	 to	
evaluate	the	evolution	of	the	hypoalgesic	effects	along	a	short	period	of	time	following	the	
stimulation	session.		
Two	 different	 areas	 of	 the	 plantar	 surface	 of	 the	 hindpaw	 were	 tested:	 the	 lateral	
(innervated	by	 tibial	and	sural	nerves)	and	the	medial	 (innervated	by	 tibial	and	saphenous	
nerves)	 regions	 (22).	 Sensibility	 to	 mechanical	 stimuli	 was	 measured	 by	 means	 of	 an	
electronic	Von	Frey	algesimeter	 (Bioseb,	Chaville,	 France).	Rats	were	placed	on	a	wire	net	
platform	 in	 plastic	 chambers	 30	 min	 before	 testing	 for	 habituation.	 Then,	 a	 non-noxious	
pointed	 probe	 was	 gently	 applied	 to	 each	 test	 site,	 slowly	 increasing	 the	 pressure.	 The	
threshold	was	expressed	as	the	force	(in	grams)	at	which	rats	withdrew	the	paw	in	response	
to	 the	 stimulus.	 A	 cutoff	 force	was	 set	 at	 45	 g	when	 the	 stimulus	 lifted	 the	 paw	without	
response.	 The	 mechanical	 nociceptive	 threshold	 was	 calculated	 as	 the	 mean	 of	 three	
measurements	per	paw	region,	obtained	with	3	min	intervals,	and	then	used	for	calculating	
the	percentage	of	the	threshold	of	injured	vs.	contralateral	intact	hindpaw	at	each	test	day.	
This	 allows	 good	 comparison	 of	 hyperalgesia	 induced	 by	 the	 injury,	 since	 no	 significant	
variations	of	the	contralateral	threshold	were	found	in	previous	studies	(9,	22,	24).	
	
2.4.	Immunohistochemistry	of	spinal	cord	
At	the	end	of	the	treatment	at	14	dpi	(half	of	the	rats	per	group)	and	at	21	dpi	(for	the	rest,	
to	 see	 possible	 variations	 one	 week	 after	 cessation	 of	 the	 treatment),	 animals	 were	
euthanized,	 and	 spinal	 cord	 samples	 were	 collected	 for	 immunohistochemical	 assays.	
Lumbar	 L4-L5	 spinal	 cord	 segments	 were	 removed	 from	 paraformaldehyde	 4%	 perfused	
animals,	kept	in	fixative	for	1	hour	and	then	cryoprotected	with	PBS	containing	30%	sucrose.	
Transverse	 sections	 were	 cut	 at	 25	 µm	 thickness	 on	 a	 cryostat	 and	 mounted	 on	 slides.	
Sections	were	blocked	with	specific	serum	and	incubated	overnight	with	primary	antibodies	
in	 0.3%	 Triton	 X-100	 in	 PBS,	 for	 staining	 microglial	 cells	 (anti-Iba1,	 goat,	 1:200,	 Abcam),	
astrocytes	 (anti-GFAP,	 rabbit,	 1:500,	 DakoCytomation),	 adrenergic	 receptors	 (anti-β2	
receptors,	 rabbit,	 1:500,	 Santa	 Cruz),	 K+-Cl-	 cotransporter	 2	 (anti-KCC2,	 rabbit,	 1:500,	
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Millipore)	and	γ-aminobutyric	acid	 (anti-GABA,	 rabbit,	1:500,	Sigma-Aldrich).	The	 following	
day,	 sections	 were	 incubated	 for	 2	 hours	 with	 Alexa	 Fluor	 488	 and/or	 Alexa	 Fluor	 594	
conjugated	secondary	antibodies	 (1:200,	 Life	Technologies).	After	washing	 in	PBS,	 sections	
were	coverslipped	with	a	solution	of	DAPI	in	Mowiol	mounting	medium.		
For	 each	marker,	 three	 sections	 from	 4	 samples	 per	 group	 and	 time	 point	were	 used	 for	
quantifying	 immunolabeling.	 20X	 images	 were	 captured	 with	 a	 Zeiss	 LSM	 700	 confocal	
microscope,	 and	 analyzed	 using	 ImageJ	 software	 (NIH,	 USA).	 Thresholding	 of	 fluorescent	
signal	was	adjusted	over	the	background	level	of	a	negative	control.	The	integrated	density	
of	 immunoreactivity	was	calculated	within	 regions	of	 interest	drawn	with	 ImageJ	 software	
tool.	Data	are	shown	for	both	ipsilateral	and	contralateral	sides.		
	
2.5.	Data	analysis	
Data	are	presented	as	mean	±	SEM.	Statistical	analysis	of	nociceptive	thresholds	was	made	
by	 two-way	 analysis	 of	 variance	 (ANOVA)	 with	 group	 and	 time	 after	 injury	 as	 factors,	
followed	 by	 Bonferroni’s	 post	 hoc	 comparisons.	 Statistical	 comparisons	 for	
immunofluorescence	data	were	made	by	two-way	ANOVA	followed	by	Tukey’s	post	hoc	test.	
The	level	of	statistical	significance	was	5%	(p<0.05).	
	
3.	Results	
	
3.1.	Hyperalgesia	is	reduced	by	chronic	electrical	stimulation	after	SNTR	
Changes	in	sensory	thresholds	were	recorded	at	both	medial	and	lateral	sites	of	the	hindpaw	
to	monitor	the	contribution	to	hyperalgesia	of	collateral	sprouting	of	the	 intact	saphenous	
nerve,	 and	 of	 denervation	 by	 the	 injured	 sciatic	 nerve.	 After	 SNTR	 the	 lateral	 side	 of	 the	
injured	hindpaw	was	unresponsive	during	the	21	days	follow-up,	since	this	territory	remains	
denervated	until	 at	 least	 4	weeks	 after	 injury	 (data	not	 shown)	 (22,	 24).	On	 the	 contrary,	
sciatic	 nerve	 injury	 produced	 a	marked	 decrease	 of	 the	mechanical	 pain	 threshold	 at	 the	
medial	side	of	the	hindpaw	from	3	to	21	dpi	(Fig.	1A-C).		
Repeated-acute	electrical	stimulation,	consisting	 in	1	hour	stimulation	given	at	3,	7	and	14	
dpi,	 induced	a	rapid	but	temporary	hypoalgesic	effect	in	the	rAES	group.	Immediately	after	
stimulation,	the	reduction	of	the	mechanical	threshold	was	significantly	prevented	(p<0.05),	
but	 this	effect	declined	after	5	hours	and	was	 completely	 lost	 at	 the	pre-stimulation	 tests	
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performed	at	7	and	14	dpi	(Fig.	1A).	On	the	other	hand,	applying	chronic	daily	treatments	by	
CES	(Fig.	1B)	and	iCES	(Fig.	1C),	the	prevention	of	hyperalgesia	was	more	sustained	along	the	
time.	The	maintenance	of	the	immediate	effect	over	time	poststimulation	was	enhanced	in	
the	iCES	group	slightly	more	than	in	the	CES	group,	and	in	both	significantly	more	than	in	the	
rAES	group.		
	
3.2.	Chronic	electrical	stimulation	reduced	glial	cell	reactivity	in	the	dorsal	horn	after	SNTR	
After	 SNTR,	 there	 was	 an	 increase	 in	 immunoreactivity	 for	 GFAP,	 showing	 hypertrophied	
astrocytes	 in	 the	dorsal	horn	of	 the	 spinal	 cord	 in	both	 sides	 compared	 to	naïve	 rats	 (Fig.	
2A,B).	 Repeated-acute	 electrical	 stimulation	 had	 no	 effect	 in	 reducing	 this	 increase	 of	
astrocyte	 reactivity	 at	 14	 or	 21	 dpi	 (Fig.	 2B).	 However,	 both	 chronic	 electrical	 stimulation	
treatments	induced	a	clear	reduction	in	GFAP	expression	to	levels	similar	to	naïve	animals.	
After	 SNTR,	 there	was	 also	marked	microglial	 reactivity,	 evidenced	 by	 an	 increase	 in	 Iba1	
immunoreactivity	 in	 the	 dorsal	 horn	 compared	 to	 naïve	 rats	 (Fig.	 3A).	 rAES	 treatment	
showed	no	significant	differences	with	respect	to	the	SNTR	group	at	14	or	21	dpi	(Fig.	3B).	
iCES	treatment	counteracted	the	increase	of	Iba1	expression	in	the	ipsilateral	dorsal	horn	at	
14	and	21	dpi	(Fig.	3B;	p<0.05),	and	CES	treatment	only	at	21	dpi	(Fig.	3B;	p<0.05),	compared	
to	SNTR	rats.	There	was	a	tendency,	although	not	significant,	to	reduce	Iba1	overexpression	
with	chronic	stimulation	treatments	in	the	contralateral	dorsal	horn.	
	
3.3.	Chronic	electrical	stimulation	reverted	the	decrease	of	KCC2	expression	in	the	dorsal	horn	
after	SNTR	
The	decline	in	KCC2	expression	following	pathological	changes	in	glial	cells	activity	results	in	
neuronal	 hyperexcitability	 due	 to	 a	 decline	 of	 the	 normally	 inhibitory	 interneurons	 (16).	
After	 SNTR	we	 found	a	marked	and	 sustained	 reduction	of	 KCC2	 levels	 in	 the	dorsal	 horn	
bilaterally	 for	at	 least	3	weeks	 (Fig.	4A),	 in	agreement	with	a	previous	report	 (19).	Chronic	
but	not	acute	repeated	electrical	stimulation	protocols	were	effective	reverting	the	decrease	
of	KCC2.	CES	and	iCES	significantly	counteracted	the	KCC2	reduction	in	the	injured	side	at	14	
and	21	dpi,	and	iCES	also	in	the	contralateral	side	at	21	dpi	compared	to	untreated	SNTR	rats	
(Fig.	4B;	p<0.05).	
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3.4.	 Chronic	 electrical	 stimulation	 reverted	 the	 decrease	 of	 β2	 receptor	 expression	 in	 the	
dorsal	horn	after	SNTR	
We	found	the	β2	receptor	expressed	in	laminae	I-III	of	the	dorsal	horn	in	the	naïve	rats	(Fig.	
5A).	 SNTR	 reduced	 the	 expression	 of	 β2	 receptor	 in	 both	 the	 ipsilateral	 and	 contralateral	
dorsal	horn	laminae.	The	expression	of	β2	was	not	restored	by	rAES	but	chronic	stimulation	
with	CES	and	iCES	protocols	was	effective	in	maintaining	β2	expression	levels	close	to	naïve	
values	in	the	ipsilateral	side	at	14	and	21	dpi	(Fig	5B;	p<0.05).	In	the	contralateral	side,	only	
iCES	 treatment	 counteracted	 the	 decrease	 of	 β2	 expression	 levels	 after	 SNTR	 (Fig.	 5B;	
p<0.05).	
	
3.5.	Chronic	electrical	stimulation	prevented	the	decrease	of	GABA	in	dorsal	horn	after	SNTR	
Because	of	the	relation	between	adrenergic	receptors	and	GABA	in	spinal	inhibition	(25)	and	
a	previous	 report	 showing	 that	GABA	 release	 in	 the	 spinal	 cord	mediated	 the	hypoalgesic	
effect	of	transcutaneous	electrical	nerve	stimulation	(TENS)	(Maeda	et	al.,	2007),	we	studied	
the	 expression	 of	 GABA	 in	 the	 spinal	 cord	 dorsal	 horn.	We	 found	 that	 the	 expression	 of	
GABA	 in	 lamina	 I,	 II	and	 III	was	reduced	 in	both	sides	of	 the	spinal	cord	at	14	and	21	days	
after	SNTR.	CES	and	 iCES,	but	not	 rAES,	 treatments	counteracted	 the	decrease	of	GABA	 in	
the	dorsal	horn	after	SNTR	in	both	sides	at	14	and	21	dpi	(Fig.	6B;	p<0.05).	
	
4.	Discussion	
The	 results	 of	 this	 study	 demonstrate	 the	 beneficial	 effects	 of	 three	 different	 patterns	 of	
electrical	stimulation	delivered	to	the	injured	sciatic	nerve	on	the	signs	of	hyperalgesia	and	
associated	changes	 in	 the	nociceptive	pathway.	 Interestingly,	 the	hypoalgesic	effects	were	
persistent	only	when	stimulation	was	applied	daily	during	at	least	2	weeks	after	injury	(CES	
and	 iCES)	 but	 not	 when	 stimulation	 sessions	 were	 repeated	 at	 intervals	 of	 several	 days	
(rAES).		
	
4.1.	Effects	of	chronic	electrical	stimulation	on	neuropathic	pain	
Peripheral	nerve	stimulation	has	been	reported	as	an	effective	treatment	for	individuals	with	
a	 variety	 of	 pain	 conditions,	 particularly	 for	 patients	 with	 neuropathic	 pain	 (1-2,	 26-27).	
Previous	studies	showed	that,	irrespective	of	the	methodology	used	(in	terms	of	frequency,	
intensity	and	duration	of	application),	peripheral	electrical	stimulation	inhibited	hyperalgesia	
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in	rat	models	of	peripheral	neuropathy	(10,	28-30).	The	frequency	of	stimulation	may	be	a	
key	 factor.	 Although	 there	 are	 different	 studies	 of	 nerve	 stimulation	 for	 neuropathic	 pain	
showing	good	results	in	reducing	hyperalgesia	by	applying	different	frequencies	(5-7,	31),	we	
focused	in	50	Hz	because	is	the	most	commonly	used	for	pain	therapies	in	the	clinic	and	has	
been	validated	in	preclinical	models	of	neuropathic	pain	(see	32,	33)	and	supported	by	our	
preliminary	assays.	Alternating	the	frequencies	of	stimulation	induces	a	variation	in	the	pain	
thresholds	 (34)	and	high	 frequencies	are	known	to	be	able	 to	block	conduction	 in	C-fibers	
(35).	Activity	dependent	treatments,	like	treadmill	running,	have	been	also	demonstrated	to	
be	effective	 in	reducing	neuropathic	pain	and	one	of	the	most	efficient	treadmill	protocols	
for	injured	rats	consists	in	an	increasing-intensity	(velocity)	exercise	(iTR)	(8-9,	24).	For	both	
types	of	activity-dpeendent	therapies,	an	early	start	is	important,	since	this	may	prevent	the	
development	of	plastic	changes	in	spinal	circuitry	and	neuroinflammatory	responses	induced	
by	the	nerve	 injury	(8,	9,	36).	Taking	these	works	 into	account,	we	mimicked	the	 inputs	of	
the	running	locomotion	of	the	rats	and	we	extrapolated	the	iTR	to	a	protocol	of	stimulation	
named	 iCES,	 in	which	 the	 rats	are	 stimulated	with	 trains	of	pulses	 increasing	 in	 frequency	
over	one	hour	per	session.	The	results	we	found	in	this	study	present	this	chronic	pattern	as	
the	most	effective	 in	reducing	mechanical	hyperalgesia	after	sciatic	nerve	 injury	compared	
to	 rAES	 and	 CES	 treatments.	 The	 effect	 of	 one	 session	 of	 peripheral	 electrical	 stimulation	
was	 shown	 previously	 to	 last	 up	 to	 12	 hours,	 and	 repetitive	 stimulation	 required	 for	 a	
cumulative	 effect	 (10),	 in	 agreement	with	 our	 results.	 Interestingly,	 in	 our	 protocols,	 iCES	
and	 to	 a	 lesser	 degree	 CES	 produced	 long-lasting	 hypoalgesia	 at	 21	 days	 despite	 the	
treatment	was	interrupted	at	14	days	after	the	lesion.	
	
4.2.	Effects	of	chronic	electrical	stimulation	on	glial	reactivity	in	the	dorsal	horn	after	SNTR	
Peripheral	 nerve	 injuries	 provoke	 changes	 in	 spinal	 microglia	 including	 proliferation,	
hypertrophy,	and	overexpression	of	cytokines	and	chemokines,	that	contribute	to	sustained	
plastic	changes	 in	 the	dorsal	horn	 favoring	pain	sensation	 (37,	38).	Microglia	play	a	role	 in	
the	 initiation	 phase	 of	 neuropathic	 pain,	 and	 their	 proliferation	 is	 related	 with	 the	
development	 of	 neuropathic	 pain	 (39).	 Activation	 of	 microglia	 has	 been	 described	 to	 be	
regulated	 by	 β2	 adrenergic	 receptor	 activation	 (14-15)	 and	 plays	 an	 active	 role	 in	 the	
pathway	 that	 leads	 to	 BDNF	 overproduction	 and	 KCC2	 dephosphorylation	 in	 neuropathic	
pain	 states	 (19).	We	evaluated	microglial	 activation	after	 SNTR	and	we	 found	a	 significant	
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capacity	of	chronic	stimulation	treatments	to	reduce	microglial	activation	in	the	dorsal	horn	
of	 the	 spinal	 cord	 after	 injury.	 In	 this	 regard,	 activation	 of	 astrocytes	 is	 also	 involved	 in	
neuropathic	 pain,	 especially	 during	 the	 chronic	 phase	 of	 pain.	 Our	 data	 showed	 that	
suppression	 of	 astrocyte	 activation	 in	 the	 spinal	 cord	 after	 SNTR	 also	 occurred	 only	 by	
chronic	but	not	acute	electrical	stimulation	treatment.		
	
4.3.	 Effects	 of	 chronic	 electrical	 stimulation	 on	 the	 expression	 of	 biomarkers	 in	 the	 dorsal	
horn	after	SNTR	
Activated	microglia	is	known	to	release	BDNF	after	a	nerve	injury	that	triggers	neuropathic	
mechanisms,	 such	 as	 downregulation	of	 KCC2	 (16,	 17,	 19)	 resulting	 in	 neuronal	 excitation	
when	 normally	 inhibitory	 GABAergic	 synapses	 are	 activated	 after	 peripheral	 nerve	 injury.	
Activation	of	GABAergic	 inputs	to	neurons	in	which	the	KCC2	transporter	 is	downregulated	
results	 in	 markedly	 increased	 levels	 of	 spontaneous	 activity	 (40,	 41).	 Our	 work	 supports	
previous	studies	with	other	activity-dependent	 treatments,	 such	as	 iTR	 (9),	 that	prevented	
the	decreased	expression	of	KCC2	after	nerve	injury.		
On	the	other	hand,	adrenergic	neurotransmission	is	implicated	in	the	hypoalgesic	effects	of	
antidepressants	 as	 well	 as	 of	 electrical	 spinal	 cord	 stimulation	 (SCS)	 (42,	 43).	 Electrical	
stimulation	 induces	 release	 of	 noradrenaline	 in	 the	 spinal	 cord	 that	 acts	 on	 adrenergic	
receptors;	α1	and	α2	adrenoceptors	have	been	shown	to	be	involved	in	pain	modulation	and	
in	neuropathic	pain	(44),	but	the	β2	receptor	is	also	expressed	in	the	dorsal	horn	of	the	spinal	
cord	 (45).	 Moreover,	 pharmacological	 stimulation	 of	 β2	 receptor	 suppressed	 neuropathic	
pain	after	sciatic	nerve	 insult	 (12).	 In	a	previous	study,	we	 found	that	 iTR	 training	strongly	
increased	the	expression	of	β2	receptor	after	peripheral	nerve	injury,	participating	in	the	iTR-
induced	 reduction	 of	 hyperalgesia	 (13).	 The	 present	 results	 also	 indicate	 that	 chronic	
electrical	 stimulation	 protocols	 are	 able	 to	 counteract	 the	 reduction	 of	 β2	 receptor	
expression	 after	 SNTR.	 Activation	 of	 β2	 receptor	 plays	 a	 role	 in	 the	 modulation	 of	 the	
microglial	inflammatory	response	to	nerve	injury	(13).	
	
4.4.	 Effects	 of	 chronic	 electrical	 stimulation	 on	 the	 expression	 of	 GABA	 in	 the	 dorsal	 horn	
after	SNTR	
Alterations	in	dorsal	horn	network	connectivity	provoked	by	a	progressive	loss	of	inhibitory	
mechanisms	contribute	to	the	progression	of	neuropathic	pain.	Following	a	peripheral	nerve	
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lesion	there	 is	 loss	of	A-fiber	mediated	 inhibition	on	nociceptive	dorsal	horn	neurons	 (46),	
that	 can	 be	 explained	 in	 part	 by	 the	 reduction	 in	 GABA-mediated	 inhibitory	 postsynaptic	
currents	in	the	dorsal	horn	due	to	the	death	of	GABAergic	interneurons	and	reduction	in	the	
amount	of	GABA	released	into	the	dorsal	horn	(47).		
In	 this	 sense,	 it	was	 reported	 that	 low	 frequency	TENS	 induces	 release	of	 serotonin	 in	 the	
spinal	 cord	 resulting	 in	 increased	 release	 of	GABA	 that	 subsequently	 decreases	 activity	 of	
dorsal	horn	neurons.	Also,	high	frequency	TENS	activates	supraspinal	δ	opioid	receptors	that	
release	GABA	and	enkephalins	in	the	spinal	cord	resulting	in	decreased	release	of	glutamate	
and	decreased	activity	of	dorsal	horn	neurons	(20).	Other	works	reported	that	noradrenaline	
enhances	 the	 spinal	 GABAergic	 and	 cholinergic	 transmission	 by	 activating	 α1	 and	 α2	
adrenoreceptors	(48).	Our	data	suggest	that	chronic	electrical	stimulation	triggers	a	series	of	
changes	in	the	spinal	cord	such	as	the	restoration	of	expression	of	KCC2	and	β2	receptor	that	
act	 facilitating	 the	 increase	 of	 GABA	 release	 in	 the	 spinal	 cord	 and	 the	 reduction	 of	 pain	
transmission	after	SNTR.	
	
5.	Conclusions	
The	 results	 of	 this	 study	 bring	 new	 knowledge	 on	 the	 contribution	 of	 peripheral	 nerve	
electrical	 stimulation	 in	 reducing	 neuropathic	 pain.	 Through	 restoration	 of	 β2	 receptor	
expression	and	reduction	of	activated	glial	cells,	daily	stimulation	during	2	weeks	after	nerve	
injury	 seems	 to	 act	 preventing	 the	 KCC2	 down-regulation,	 leading	 to	 a	 higher	 release	 of	
GABA	 and	 reduction	 of	 the	 hyperalgesic	 state.	 Future	 studies	 are	 needed	 to	 understand	
more	about	these	interactions	and	which	neuronal	populations	and	molecular	mechanisms	
are	 involved.	 Patterned	 stimulation	 as	 with	 our	 increasing-frequency	 chronic	 electrical	
stimulation	 protocol	 shows	 promise	 towards	 improving	 the	 effectiveness	 of	 electrical	
stimulation	therapy	in	clinical	applications.	
	
Abbreviations:	 SNTR,	 sciatic	 nerve	 transection	 and	 repair;	 rAES,	 repeated	 single	 electrical	
stimulation;	CES,	chronic	electrical	stimulation;	iCES,	 increasing-frequency	chronic	electrical	
stimulation;	 KCC2,	 K+-Cl-	 cotransporter	 2;	 GABA,	 γ-aminobutyric	 acid;	 BDNF,	 brain-derived	
neurotrophic	 factor;	GFAP,	Glial	 fibrillary	acidic	protein;	 i.p.,	 intraperitoneal;	dpi,	days	post	
injury;	 TENS,	 transcutaneous	 electrical	 stimulation;	 iTR,	 increasing-intensity	 treadmill	
exercise;	SCS,	spinal	cord	stimulation.	
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Figures	
	
Figure	1.	Hyperalgesia	is	reduced	by	chronic	stimulation	after	SNTR.	Changes	in	mechanical	
sensory	thresholds	recorded	at	the	medial	(D)	test	site	in	rAES	(A),	CES	(B)	and	iCES	groups	
(C)	after	SNTR	from	3	dpi	pre-stimulation	to	21	dpi.	Recordings	were	performed	before	and	
also	post-stimulation	and	at	1	and	5	hours	post-stimulation.	Values	are	represented	as	the	
percent	ratio	between	the	mean	ipsilateral	and	the	contralateral	paw.	*	p<0.05,	**	p<0.01,	
***	p<0.001.		
	
Figure	 2.	 Chronic	 stimulation	 reduced	 GFAP	 overexpression	 in	 dorsal	 horn	 after	 SNTR.	 (A)	
Representative	confocal	images	of	GFAP	immunoreactivity	in	the	spinal	cord	dorsal	horn	of	
naïve	rats,	and	in	the	ipsilateral	and	contralateral	dorsal	horns	at	14	dpi	of	SNTR,	SNTR+rAES,	
SNTR+CES	and	SNTR+iCES	rats,	with	graphic	representation	of	laminae	I,	II	and	III	as	regions	
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of	 interest	 considered	 for	 quantification.	 Scale	 bar	 100μm.	 (B)	 Quantification	 of	 GFAP	
immunoreactivity	 in	 the	 ipsilateral	 and	 contralateral	 dorsal	 horn	 of	 naïve,	 and	 SNTR	 rats	
compared	with	the	electrical	stimulation		treatments	at	14	and	21	dpi.	*	p<0.05.	
	
	
	
	
Figure	3.	Chronic	stimulation	counteracted	the	 increase	of	 Iba1	expression	 in	the	 ipsilateral	
dorsal	horn	after	SNTR.	(A)	Representative	confocal	images	of	Iba1	immunoreactivity	in	the	
spinal	cord	dorsal	horn	of	naïve	rats,	and	in	the	ipsilateral	and	contralateral	dorsal	horns	at	
14	dpi	of	SNTR,	SNTR+rAES,	SNTR+CES	and	SNTR+iCES	 rats,	with	graphic	 representation	of	
laminae	I,	II	and	III	as	regions	of	interest	considered	for	quantification.	Scale	bar	100μm.	(B)	
Quantification	 of	 Iba1	 immunoreactivity	 in	 the	 ipsilateral	 and	 contralateral	 dorsal	 horn	 of	
naïve	and	SNTR	rats	compared	with	the	electrical	stimulation	treatments	at	14	and	21	dpi.	*	
p<0.05.	
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Figure	 4.	Chronic	 stimulation	 reverted	 the	 decrease	 of	 KCC2	 expression	 in	 the	 dorsal	 horn	
after	 SNTR.	 (A)	 Representative	 confocal	 images	 of	 KCC2	 immunoreactivity	 in	 the	 spinal	
dorsal	horn	of	naïve	 rats,	and	 in	 the	 ipsilateral	and	contralateral	dorsal	horns	at	14	dpi	of	
SNTR,	SNTR+rAES,	SNTR+CES	and	SNTR+iCES	rats,	with	graphic	representation	of	laminae	I,	II	
and	 III	 as	 regions	 of	 interest	 considered	 for	 quantification.	 Scale	 bar	 100μm.	 (B)	
Quantification	of	KCC2	in	the	ipsilateral	and	contralateral	dorsal	horn	of	naïve,	and	SNTR	rats	
compared	with	the	electrical	stimulation	treatments	at	14	and	21	dpi.	*	p<0.05.	
	
	
Figure	5.	Chronic	stimulation	counteracted	the	decrease	of	β2	 receptor	expression	 in	dorsal	
horn	 after	 SNTR.	 (A)	 Representative	 confocal	 images	 of	 β2	 adrenergic	 receptor	
immunoreactivity	 in	 the	 spinal	 dorsal	 horn	 of	 naïve	 rats,	 and	 in	 the	 ipsilateral	 and	
contralateral	dorsal	horns	at	14	dpi	of	SNTR,	SNTR+rAES,	SNTR+CES	and	SNTR+iCES	rats,	with	
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graphic	 representation	 of	 laminae	 I,	 II	 and	 III	 as	 regions	 of	 interest	 considered	 for	
quantification.	Scale	bar	100μm.	(B)	Quantification	of	β2	 immunoreactivity	 in	the	 ipsilateral	
and	 contralateral	 dorsal	 horn	 of	 naïve,	 and	 SNTR	 rats	 compared	 with	 the	 electrical	
stimulation	treatments	at	14	and	21	dpi.	*	p<0.05,	**	p<0.01.	
	
	
Figure	6.	Chronic	stimulation	counteracted	the	decrease	of	GABA	in	dorsal	horn	after	SNTR.	
(A)	Representative	confocal	 images	of	GABA	 immunoreactivity	 in	 the	 spinal	dorsal	horn	of	
naïve	 rats,	 and	 in	 the	 ipsilateral	 and	 contralateral	 dorsal	 horns	 of	 SNTR,	 SNTR+rAES,	
SNTR+CES	and	SNTR+iCES	rats	at	14	dpi,	with	graphic	representation	of	laminae	I,	II	and	III	as	
regions	 of	 interest	 considered	 for	 quantification.	 Scale	 bar	 100μm.	 (B)	 Quantification	 of	
GABA	in	the	ipsilateral	and	contralateral	dorsal	horn	of	naïve,	and	SNTR	rats	compared	with	
the	 electrical	 stimulation	 treatments	 at	 14	 and	 21	 dpi.	 *	 p<0.05,	 **	 p<0.01,	 ***	 p<0.001,	
****	p<0.0001.	
	
	
